Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer)
- PMID: 22562091
- DOI: 10.1007/s00330-012-2470-x
Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer)
Abstract
Objectives: To compare the diagnostic performance of ultrasound, contrast-enhanced computed tomography (CT) and (18)F-FDG positron emission tomography (PET)/CT for detecting recurrent differentiated thyroid cancer in the neck.
Methods: Twenty patients who had undergone previous surgery for differentiated thyroid cancer (19 papillary carcinomas; 1 medullary carcinoma) and presented with pathologically proven recurrence in the neck were included. All patients had undergone ultrasound, CT and PET/CT in the 2 months before further surgery. In each patient, ultrasound, CT and PET/CT images were retrospectively reviewed to determine the presence of loco-regional recurrence by level-by-level analysis. Imaging results were correlated with the histological evaluation of the neck dissection as a standard of reference.
Results: Recurrences were found at 52 out of 110 cervical nodal levels surgically explored. The sensitivity, specificity and accuracy were 69.2 %, 89.7 % and 80.0 % for ultrasound; 63.5 %, 94.8 % and 80.0 % for CT; and 53.8 %, 79.3 % and 67.3 % for PET/CT, respectively. ROC analysis revealed higher diagnostic performance with ultrasound than with PET/CT for detecting recurrent tumour.
Conclusions: Although no significant difference was found among the three techniques, the sensitivity and specificity of ultrasound and CT were higher than those of PET/CT for the evaluation of cervical recurrence in patients with differentiated thyroid cancer.
Key points: • Ultrasound, CT and ( 18 ) F-FDG PET/CT can all detect recurrent thyroid cancer. • Ultrasound and CT have higher sensitivity and specificity. • Ultrasound, CT and ( 18 ) F-FDG PET/CT frequently demonstrated discordant findings.
Similar articles
-
Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.Head Neck. 2018 Jan;40(1):94-102. doi: 10.1002/hed.24967. Epub 2017 Nov 11. Head Neck. 2018. PMID: 29130586
-
Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.Nucl Med Commun. 2011 Dec;32(12):1162-8. doi: 10.1097/MNM.0b013e32834bbe09. Nucl Med Commun. 2011. PMID: 21946617
-
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19. Eur Radiol. 2016. PMID: 26188656
-
¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.J Med Imaging Radiat Oncol. 2012 Apr;56(2):136-42. doi: 10.1111/j.1754-9485.2012.02344.x. Epub 2012 Mar 6. J Med Imaging Radiat Oncol. 2012. PMID: 22498184 Review.
-
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.AJR Am J Roentgenol. 2015 Sep;205(3):629-39. doi: 10.2214/AJR.14.14166. AJR Am J Roentgenol. 2015. PMID: 26295652 Review.
Cited by
-
Diagnostic potential of ultrasonography and computed tomography in differentiating cervical lymph node metastasis of thyroid cancer: a systematic review and meta-analysis.Arch Med Sci. 2020 May 11;19(4):965-975. doi: 10.5114/aoms.2020.95104. eCollection 2023. Arch Med Sci. 2020. PMID: 37560722 Free PMC article. Review.
-
Diagnostic value of contrast-enhanced ultrasound in papillary thyroid microcarcinoma.Exp Ther Med. 2016 May;11(5):1555-1562. doi: 10.3892/etm.2016.3094. Epub 2016 Feb 19. Exp Ther Med. 2016. PMID: 27168773 Free PMC article.
-
MRI and ultrasonography detection of cervical lymph node metastases in differentiated thyroid carcinoma before reoperation.Am J Transl Res. 2014 Jan 15;6(2):147-54. eCollection 2014. Am J Transl Res. 2014. PMID: 24489994 Free PMC article.
-
Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes.Eur Radiol. 2014 Oct;24(10):2513-9. doi: 10.1007/s00330-014-3288-5. Epub 2014 Jul 9. Eur Radiol. 2014. PMID: 25005826
-
Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma.Rambam Maimonides Med J. 2016 Jan 28;7(1):e0006. doi: 10.5041/RMMJ.10233. Rambam Maimonides Med J. 2016. PMID: 26886954 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical